These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7404505)

  • 1. Protective effect of ticlopidine on experimentally induced peripheral arterial occlusive disease in rats.
    Ashida S; Ishihara M; Ogawa H; Abiko Y
    Thromb Res; 1980 Apr 1-15; 18(1-2):55-67. PubMed ID: 7404505
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt model in rats.
    Ashida S; Sakuma K; Abiko Y
    Thromb Res; 1980 Mar; 17(5):663-71. PubMed ID: 7385100
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental model of venous thrombosis in rats and effect of some agents.
    Kumada T; Ishihara M; Ogawa H; Abiko Y
    Thromb Res; 1980 Apr 1-15; 18(1-2):189-203. PubMed ID: 7404498
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of various antiplatelet drugs and defibrinating agent on experimental glomerulonephritis in rats.
    Ogawa S; Naruse T
    J Lab Clin Med; 1982 Mar; 99(3):428-41. PubMed ID: 6460069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombotic effect of ticlopidine in a platelet-independent model of venous thrombosis.
    Bernat A; Vallée E; Maffrand JP; Roncucci R
    Thromb Res; 1985 Jan; 37(2):279-85. PubMed ID: 3975872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function.
    Picard-Fraire C
    Thromb Res Suppl; 1983; 4():119-28. PubMed ID: 6356462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo and in vivo evaluation of drugs that inhibit platelet function.
    Hanson SR; Harker LA
    Ann N Y Acad Sci; 1983; 416():642-50. PubMed ID: 6587821
    [No Abstract]   [Full Text] [Related]  

  • 9. Ticlopidine - an antiplatelet drug: effects in human volunteers.
    O'Brien JR; Etherington MD; Shuttleworth RD
    Thromb Res; 1978 Aug; 13(2):245-54. PubMed ID: 694843
    [No Abstract]   [Full Text] [Related]  

  • 10. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compared effects of three dose-levels of ticlopidine on platelet function in normal subjects.
    David JL; Monfort F; Herion F; Raskinet R
    Thromb Res; 1979 Jan; 14(1):35-49. PubMed ID: 425084
    [No Abstract]   [Full Text] [Related]  

  • 12. The interactions of ticlopidine and aspirin in normal subjects.
    Thebault JJ; Blatrix CE; Blanchard JF; Panak EA
    J Int Med Res; 1977; 5(6):405-11. PubMed ID: 590598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ticlopidine on arachidonic acid metabolism in platelet phospholipids in vitro.
    Chap H; Simon MF; Douste-Blazy L
    Biochem Pharmacol; 1981 Jun; 30(12):1463-8. PubMed ID: 7271841
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet drugs in the management of patients with thrombotic disorders.
    Harker LA
    Semin Thromb Hemost; 1986 Apr; 12(2):134-55. PubMed ID: 3016905
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of ticlopidine and acetylsalicylic acid on generation of prostaglandin I2-like substance in rat arterial tissue.
    Ashida S; Abiko Y
    Thromb Res; 1978 Nov; 13(5):901-8. PubMed ID: 369031
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypothetic mechanism of ticlopidine-induced hypersensitivity to PGE1 in rat platelets.
    Bonne C; Martin B; Regnault F
    Thromb Res; 1981 Jan 1-15; 21(1-2):157-64. PubMed ID: 6262943
    [No Abstract]   [Full Text] [Related]  

  • 17. Adenosine diphosphate (ADP)-induced alpha-granules release from platelets of native whole blood is reduced by ticlopidine but not by aspirin or dipyridamole.
    Pengo V; Boschello M; Marzari A; Baca M; Schivazappa L; Dalla Volta S
    Thromb Haemost; 1986 Oct; 56(2):147-50. PubMed ID: 3810554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet aggregators inhibit development of stress ulcers in Sprague-Dawley rats.
    Kumashiro R; Piotrowski JJ; Kholoussy AM; Hashimoto N; Matsumoto T
    Eur Surg Res; 1985; 17(1):44-52. PubMed ID: 3972005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.
    de Gaetano G; Bertelé V
    Agents Actions; 1984 Jan; 14(1):109-12. PubMed ID: 6702507
    [No Abstract]   [Full Text] [Related]  

  • 20. [Platelet function inhibitors in peripheral arteriopathies].
    Strano A; Davì G; Cannizzaro S; Giubilato A
    Recenti Prog Med; 1986 Apr; 77(4):205-9. PubMed ID: 2872704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.